1. Report Introduction 2. Gallbladder Cancer Overview 3. Pipeline Therapeutics • An Overview of Pipeline Products for Gallbladder Cancer 4. Comparative Analysis 5. Products in Clinical Stage 5.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 6. Products in Pre-Clinical and Discovery Stage 6.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 7. Therapeutic Assessment • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type 8. Inactive Products 8.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities Appendix Report Methodology Consulting Services Disclaimer About DelveInsight

Table 1: Total Products for Gallbladder Cancer Table 2: Products in Clinical Stage Table 3: Products in Non-clinical Stage Table 4: Assessment by Route of Administration Table 5: Assessment by Stage and Route of Administration Table 6: Assessment by Molecule Type Table 7: Assessment by Stage and Molecule Type Table 8: Inactive Products Figure 1: Total Products for Gallbladder Cancer Figure 2: Products in Clinical Stage Figure 3: Products in Non-clinical Stage Figure 4: Assessment by Route of Administration Figure 5: Assessment by Stage and Route of Administration Figure 6: Assessment by Molecule Type Figure 7: Assessment by Stage and Molecule Type Figure 8: Inactive Products

Adherex Technologies Inc. Advenchen Laboratories LLC Array BioPharma Inc Aslan Pharmaceuticals Pte Ltd Bayer AG BeiGene Ltd GlaxoSmithKline Halozyme Therapeutics Inc Hutchison China MediTech Ltd Leap Therapeutics Inc Merrimack Pharmaceuticals Inc Novartis AG NuCana BioMed Ltd Threshold Pharmaceuticals Inc VasGene Therapeutics Inc Shire & list continues...